The Long-term Care Tech Portal, managed by a dedicated office and supported by the Japan Agency for Medical Research and ...
A stem cell treatment helped improve the motor function of two out of four patients with a spinal cord injury in the first ...
Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...
Rhythm Pharmaceuticals received an orphan-drug designation from Japan's Ministry of Health, Labour and Welfare for its treatment for a certain type of obesity.
A Japanese research team found that the oxidized form of glutathione (GSSG) may protect heart tissue by modifying a key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results